Evidence map›Paper›PMID 40895629›Full record

ArticleFrontiers in endocrinology2025

Study on the relationship between homocysteine and general metabolic indexes in healthy population in Hebei Province, China.

Hongru Feng, Xiaoliang Wang, Lili Yu, Qianqian Zheng, Zhaoqi Wang

Abstract read
In one paragraph

Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Hongru FengDepartment of Physical Examination Center, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
Xiaoliang WangDepartment of Neurosurgery, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
Lili YuDepartment of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
Qianqian ZhengDepartment of Metabolic Regulation, Shinshu University School of Medicine, Matsumoto, Japan.
Zhaoqi WangDepartment of Physical Examination Center, The Second Hospital of Hebei Medical University, Shijiazhuang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The aging problem is a significant issue and challenge currently faced by the whole world. Hyperhomocysteinemia (HHcy) is a common phenomenon among the older adult. Increasing evidence suggests a link between HHcy and multiple systemic issues in the older adult-related diseases. Therefore, the identification of high-risk factors for HHcy in a healthy screening population can effectively regulate the occurrence, progression of HHcy, thereby reducing the incidence of older adult-related diseases. Methods: A total of 10,511 individuals who underwent a comprehensive health examination at the Second Hospital of Hebei Medical University, China from 2021 to 2022 were included. Data on gender, age, carotid ultrasound(CCA), blood pressure(BP), body mass index(BMI), serum levels of homocysteine(Hcy), total cholesterol(TC), triglycerides(TG), low-density lipoprotein(LDL-C), high-density lipoprotein(HDL-C), alanine aminotransferase(ALT), aspartate aminotransferase(AST), red blood cells(RBC), creatinine(Cr), urea, uric acid(UA), fasting blood-glucose(FBG), and glycated hemoglobin(GHb) concentration were collected. Results: Hyperhomocysteinemia was associated with gender, age, BP, CCA, BMI, elevated levels of TC, TG, LDL-C, Cr, urea, UA, as well as decreased levels of HDL-C and RBC. Among these factors male, above 65 years old age, hypertension, carotid artery abnormalities, UA, and Cr were identified as independent risk factors, while HDL-C and RBC were identified as protective factors. Conclusion: The prevalence of HHcy was very high during routine physical examination especially the senior citizens in Hebei Province, China. Therefore, high-risk populations should be the focus of public health policies, and strengthening early intervention can reduce the occurrence of HHcy, thereby delaying the onset and progression of older adult-related diseases.

Indexed as

BiomarkersHomocysteineHyperhomocysteinemiaAdultAgedBody Mass IndexChinaFemaleHumansMaleMiddle AgedRisk FactorsBiomarkersHomocysteinehealthy populationhigh-density lipoproteinhyperhomocysteinemiared blood cellsrisk factor

Identifiers

PMID40895629
PMCPMC12392274

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.